Avanos Medical reports Q1 2024 results; key figures not available in 8-K

AVANOS MEDICAL, INC.

2024-Q1 EPS reported -$0.02 revenue$166,100,000

Company announced results for three months ended March 31, 2024.
No specific EPS, revenue, or guidance figures included in filing text or exhibit.
Investors should refer to the full press release for detailed financial data.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

AVANOS MEDICAL, INC. reported financial results for three months ended March 31, 2024.

Period: three months ended March 31, 2024
Result: reported results

Exact text from the filing

On May 2, 2024, Avanos Medical, Inc. (the "Company") issued a press release announcing its results of operations for the three months ended March 31, 2024.

View on SEC.gov

316 earnings releases filed in the last 30 days. Browse all earnings releases →

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-24-000055

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.